Literature DB >> 24866140

Long-term sympathoinhibitory effects of surgically induced weight loss in severe obese patients.

Gino Seravalle1, Manuela Colombo1, Paolo Perego1, Vittorio Giardini1, Marco Volpe1, Raffaella Dell'Oro1, Giuseppe Mancia1, Guido Grassi2.   

Abstract

Weight loss improves insulin sensitivity and exerts sympathomodulatory effects. No data, however, are available on the effects of the weight loss induced by vertical sleeve gastrectomy on sympathetic neural drive, insulin sensitivity, and their reciprocal cross talks. In 10 severe obese hypertensives (age, 54.0±2.3 years [mean±SEM]), we measured sphygmomanometric blood pressure, heart rate, body mass index, homeostatic model assessment index, plasma leptin, muscle sympathetic nerve traffic (microneurography), and baroreflex sensitivity (vasoactive drug technique). Measurements were performed 2 to 3 days before surgery and repeated 6 and 12 months after the procedure. Ten matched hypertensive obeses not undergoing gastrectomy served as controls. Six months after bariatric surgery, a significant (P<0.05) reduction in body mass index (-9.1±1.4 kg/m(2)), sphygmomanometric systolic blood pressure (-10.2±4.5 mm Hg), heart rate (-11.0±2.4 bpm), homeostatic model assessment index (-3-3±1.3 AU), plasma leptin (-53.6±8.8 μg/L), and muscle sympathetic nerve traffic (-15.0±3.4 bursts/100 heart beats) was observed. The weight loss, the plasma leptin reduction, and the sympathetic inhibition were maintained after 12 months, whereas homeostatic model assessment index showed a tendency to return toward presurgery values. A significant improvement in baroreflex control of sympathetic nerve traffic was observed both 6 (+32.1%; P<0.05) and 12 months (+60.7%; P<0.01) after gastrectomy. No significant changes in the above-mentioned variables were detected in the control group. These data provide evidence that massive weight loss induced by sleeve gastrectomy triggers profound sympathoinhibitory effects, associated with a stable and significant reduction in plasma leptin levels, whereas the improvement in insulin sensitivity was attenuated with time and unrelated to the sympathoinhibition.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  bariatric surgery; baroreflex; body weight; insulin resistance; leptin; obesity; sympathetic nervous system

Mesh:

Substances:

Year:  2014        PMID: 24866140     DOI: 10.1161/HYPERTENSIONAHA.113.02988

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  24 in total

1.  "Broken" autonomic cardiac circadian clock in obese adolescents: evidence and implications.

Authors:  Guido Grassi
Journal:  Clin Auton Res       Date:  2014-11-01       Impact factor: 4.435

2.  Target organ complications and prognostic significance of alerting reaction: analysis from the Dallas Heart Study.

Authors:  Alejandro Velasco; Colby Ayers; Sandeep R Das; James A de Lemos; Amit Khera; Ronald G Victor; Norman M Kaplan; Wanpen Vongpatanasin
Journal:  J Hypertens       Date:  2016-02       Impact factor: 4.844

Review 3.  Hypertension in Obesity and the Impact of Weight Loss.

Authors:  Jordana B Cohen
Journal:  Curr Cardiol Rep       Date:  2017-08-24       Impact factor: 2.931

4.  QT Interval Shortening After Bariatric Surgery Depends on the Applied Heart Rate Correction Equation.

Authors:  Erik K Grasser; Barbara Ernst; Martin Thurnheer; Bernd Schultes
Journal:  Obes Surg       Date:  2017-04       Impact factor: 4.129

5.  Sleeve Gastrectomy Decreases Body Weight, Whole-Body Adiposity, and Blood Pressure Even in Aged Diet-Induced Obese Rats.

Authors:  Rafael Moncada; Amaia Rodríguez; Sara Becerril; Leire Méndez-Giménez; Víctor Valentí; Beatriz Ramírez; Javier A Cienfuegos; Secundino Fernández; Victoria Catalán; Javier Gómez-Ambrosi; Gema Frühbeck
Journal:  Obes Surg       Date:  2016-07       Impact factor: 4.129

6.  Sympathetic inhibition after bariatric surgery.

Authors:  Allyn L Mark; Andrew W Norris; Kamal Rahmouni
Journal:  Hypertension       Date:  2014-08       Impact factor: 10.190

Review 7.  Pathophysiology and Potential Non-Pharmacologic Treatments of Obesity or Kidney Disease Associated Refractory Hypertension.

Authors:  Thierry H Le Jemtel; William Richardson; Rohan Samson; Abhishek Jaiswal; Suzanne Oparil
Journal:  Curr Hypertens Rep       Date:  2017-02       Impact factor: 5.369

Review 8.  Cardiometabolic crosstalk in obesity-associated arterial hypertension.

Authors:  Jens Jordan; Andreas L Birkenfeld
Journal:  Rev Endocr Metab Disord       Date:  2016-03       Impact factor: 6.514

9.  Adrenal medullary dysfunction as a feature of obesity.

Authors:  M Reimann; N Qin; M Gruber; S R Bornstein; C Kirschbaum; T Ziemssen; G Eisenhofer
Journal:  Int J Obes (Lond)       Date:  2017-02-06       Impact factor: 5.095

Review 10.  Obesity, kidney dysfunction and hypertension: mechanistic links.

Authors:  John E Hall; Jussara M do Carmo; Alexandre A da Silva; Zhen Wang; Michael E Hall
Journal:  Nat Rev Nephrol       Date:  2019-06       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.